Premarket analyst action – healthcare – AmerisourceBergen Corporation (NYSE:ABC)


Gilead Sciences (NASDAQ:GILD) initiated with Market Perform rating by Oppenheimer. Shares up a fraction premarket.

FibroGen (NASDAQ:FGEN) initiated with Neutral rating and $61 (2% upside) price target by Mizuho Securities.

Akebia Therapeutics (NASDAQ:AKBA) initiated with Buy rating and $24 (25% upside) price target by Mizuho.

Aptevo Therapeutics (NASDAQ:APVO) resumed with Overweight rating and $6 (159% upside) price target by Piper Jaffray. Shares up 24% premarket.

Biogen (NASDAQ:BIIB) upgraded to Overweight by Morgan Stanley. Shares up 2% premarket.

AmerisourceBergen (NYSE:ABC) upgraded to Outperform with a $96 (16% upside) price target by Robert W. Baird. Shares up 3% premarket.

Celgene (NASDAQ:CELG) downgraded to Underweight by Morgan Stanley citing looming generic threat to Revlimid. Shares down 3% premarket.

Mallinckrodt (NYSE:MNK) downgraded to Hold by Canaccord Genuity. Shares down 4% premarket.

Diplomat Pharmacy (NYSE:DPLO) price target raised to $23.75 (12% upside) following its acquisition of 8th Day Software.

Source: Bloomberg

Source link

Premarket analyst action – healthcare – AmerisourceBergen Corporation (NYSE:ABC)

Tags: #Healthcare #Healthcare Info #Healthcare News #Healthcare Recipe #Healthcare Trick